Winningtemp calls Chalmers for $3.7m round

Chalmers Ventures has invested more funding in human resources app developer Winningtemp, which is preparing its employee wellbeing software for international expansion.

NYU and Futurx spark Glixogen’s genesis

New York University has teamed up with corporate-backed biopharmaceutical incubator Futurx to spawn neurodegenerative disease drug developer Glixogen Therapeutics.

Samsung trains its focus on Corephotonics

Samsung is reportedly eyeing Tel Aviv University-founded smartphone camera technology developer Corephotonics for $150m to $160m after backing its series B and C rounds.

Events

GCVI Summit 2019
30th January 2019
GCV Symposium & GUV:Fusion 2019
22nd May 2019
Investors deliver $2.5m to AmacaThera
Toronto’s AmacaThera is preparing clinical trials of a drug delivery hydrogel that could diminish the need for prescription opioid painkillers after surgery.
Croda adds value to Cutitronics’ regimen
Strathclyde-founded dermatological device manufacturer Cutitronics has collected further investment from specialty chemicals supplier Croda as the pair aim to win business with personal care brands.
Purdue breaks through 200 companies
The university has helped launch 223 businesses, including 130 based on its IP, since an overhaul of its commercialisation strategy in 2013.
News roundup 14 January 2019
A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.
Redefining university innovation in the 21st century: Part 1
Christine Gulbranson, chief innovation officer of University of California, outlines the changes her institution has enacted to support the innovation ecosystem.
ClearMotion rides investor interest to raise $115m
Microsoft, Bridgestone and Qualcomm all contributed to a series D round for MIT spinout ClearMotion, which emerged from stealth earlier last year with $130m in funding.
test reg

Login